Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
- Written by PR Newswire Asia - Asian Spectator
 |
MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company's late-stage and next-generation radiotherapeutic candidates in urologic oncology.
In this education session, Telix and global key opinion...
